PD 0200390 Dose-Ranging Trial: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Outpatient Trial of PD 0200390 in Adults With Nonrestorative Sleep.

Trial Profile

PD 0200390 Dose-Ranging Trial: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Outpatient Trial of PD 0200390 in Adults With Nonrestorative Sleep.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Jul 2012

At a glance

  • Drugs Atagabalin (Primary)
  • Indications Sleep disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Jul 2012 Additional location (Canada) added as reported by ClinicalTrials.gov.
    • 20 Jan 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
    • 20 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top